Screener
Immunovant, Inc. IMVT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026. Open the filing →
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
FAQ
- What is Immunovant, Inc.'s current ratio?
- Immunovant, Inc. (IMVT) reported current ratio of 9.1× in Q1 2026.
- How has Immunovant, Inc.'s current ratio changed year-over-year?
- Immunovant, Inc.'s current ratio decreased by 18.6% year-over-year, from 11.2× to 9.1×.
- What is the long-term trend for Immunovant, Inc.'s current ratio?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s current ratio has grown at a -16.0% compound annual growth rate (CAGR), from 21.8× to 9.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Immunovant, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude